Next Article in Journal
(R)-(+)-3,5-Dinitro-N-(1-phenylethyl)benzothioamide
Next Article in Special Issue
Synthesis of 5-Aroyl-2-aryl-3-hydroxypyridin-4(1H)-ones
Previous Article in Journal / Special Issue
5-(4-Chlorophenyl)-N,1-di-o-tolyl-1H-imidazole-2-amine
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

5,6-Dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione

by
Timofey N. Chmovzh
1,2,
Karim S. Gaisin
1,3 and
Oleg A. Rakitin
1,*
1
N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47 Leninsky Prospekt, Moscow 119991, Russia
2
Nanotechnology Education and Research Center, South Ural State University, 76 Lenina Avenue, Chelyabinsk 454080, Russia
3
Department of Chemistry, Moscow State University, Moscow 119899, Russia
*
Author to whom correspondence should be addressed.
Molbank 2023, 2023(2), M1649; https://doi.org/10.3390/M1649
Submission received: 24 April 2023 / Accepted: 16 May 2023 / Published: 18 May 2023
(This article belongs to the Collection Heterocycle Reactions)

Abstract

:
1,2,5-Chalcogenadiazoles fused with electron-withdrawing heterocycles have been actively investigated for the preparation of organic photovoltaic materials. [1,2,5]Oxadiazolo[3,4-d]pyridazines are much less studied than other chalcogenadiazolopyridazines due to their low availability. In this communication, we report our study showing that 5,6-dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione, a key precursor for the synthesis of 4,7-dihalo-[1,2,5]oxadiazolo[3,4-d]pyridazines, is formed via the cyclization of 1,2,5-oxadiazole-3,4-dicarbohydrazide in hydrochloric acid. The structure of the newly synthesized compound was established by means of elemental analysis; high-resolution mass spectrometry; 1H and 13C NMR; IR spectroscopy, and mass spectrometry.

Graphical Abstract

1. Introduction

The oxadiazolopyridazine heterocyclic system has been of interest to organic chemists for the past 50 years. The main attention is paid to various N-oxide derivatives of this heterocycle, including 1,2,5-oxadiazole N-oxides and pyridazine-di-N-oxides, which have been actively investigated as nitric oxide donors [1,2] and as high-energy compounds [1,3,4]. [1,2,5]Oxadiazolo[3,4-d]pyridazines are much less studied since the methods for their synthesis are limited by the deoxygenation of the corresponding 1,2,5-oxadiazole N-oxides. Meanwhile, these compounds have been studied for photovoltaic applications [5,6]. 4,7-Dihalogen-substituted 2,1,3-benzoxadiazoles are important precursors for the synthesis of organic solar cell (OSC) and organic light-emitting diode (OLED) components [7]. The sulfur-containing analog of the oxadiazolopyridazine, 4,7-dibromo-[1,2,5]thiadiazolo[3,4-d]pyridazine, has previously been shown to be a key precursor for a number of photovoltaic materials [8,9,10]. 4,7-Dihalo-[1,2,5]oxadiazolo[3,4-d]pyridazines can also act as useful compounds for the preparation of such materials. The key intermediate for the synthesis of these heterocycles is 5,6-dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione 1, which can be obtained from 1,2,5-oxadiazole-3,4-dicarbohydrazide 2 [11] via a procedure similar to the synthesis of 5,6-dihydro-[1,2,5]thiadiazolo[3,4-d]pyridazine-4,7-dione [12]. Herein, we report a study on the cyclization reaction of 1,2,5-oxadiazole-3,4-dicarbohydrazide 2 to 5,6-dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione 1.

2. Results and Discussion

We studied the reaction of closing the pyridazine ring in 1,2,5-oxadiazole-3,4-dicarboxylic acid dicarbohydrazide 2 under the action of hydrochloric acid in order to obtain 5,6-dihydro-[1,2,5]oxadiazolo [3,4-d]pyridazine-4,7-dione 1. Previously, we showed [12] that the closure of the pyridazine ring into dicarbohydrazide 1,2,5-thiadiazole-3,4-dicarboxylic acid proceeded successfully by refluxing in a 2N HCl solution for 6 h. However, attempts to apply this method to dicarbohydrazide 1,2,5-oxadiazole-3,4-dicarboxylic acid 2 were unsuccessful. Instead of the precipitation of compound 1, a clear brown solution was formed. Using thin-layer chromatography, it was shown that bis-hydrazide 2 completely reacted with 2N hydrochloric acid for 3 h at 75 °C. However, the yield of the target dihydropyridazindione 1 isolated via extraction with ethyl acetate was only 15% (Table 1, entry 1). It has been established that the reason for the low yield of dione 1 is its decomposition into a mixture of unidentifiable compounds when heated in 2N hydrochloric acid; thus, complete decomposition of dione 1 was observed upon heating for 6 h. The best yield of [1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione 1 (41%) was obtained by heating the reaction mixture for 1 h at 75 °C (Table 1, entry 3). A decrease in the temperature of the reaction mixture from 75 °C to 60 °C, as well as an increase in the temperature to 90 °C, did not lead to an increase in the yield of the target product 1 (Table 1, entries 4 and 5).
The structure of 5,6-dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione 1 was confirmed by means of elemental analysis; high-resolution mass spectrometry; 1H and 13C NMR; IR spectroscopy, and mass spectrometry.
In conclusion, 5,6-dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione 1 was synthesized via the ring closure reaction of 1,2,5-oxadiazole-3,4-dicarbohydrazide 2 with hydrochloric acid. The compound obtained may serve as a precursor for the preparation of 4,7-dihalo-[1,2,5]oxadiazolo[3,4-d]pyridazines.

3. Materials and Methods

1,2,5-Oxadiazole-3,4-dicarbohydrazide 2 was prepared according to the published method [11]. The solvents and reagents were purchased from commercial sources and used as received. Elemental analysis was performed using a 2400 Elemental Analyzer (Perkin ElmerInc., Waltham, MA, USA). The 1H and 13C NMR spectra were obtained with a Bruker AM-300 machine (Bruker AXS Handheld Inc., Kennewick, WA, USA) (at frequencies of 300 and 75 MHz) in an acetone-d6 solution, with TMS as the standard. The MS spectrum (EI, 70 eV) was obtained with a Finnigan MAT INCOS 50 instrument (Hazlet, NJ, USA). The high-resolution MS spectrum was measured using a Bruker micrOTOF II instrument (Bruker Daltonik Gmbh, Bremen, Germany) with electrospray ionization (ESI). The IR spectrum was measured with a Bruker “Alpha-T” instrument in KBr pellet.
5,6-Dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione 1 (CAS 898057-22-2) was commercially available from Aurora Fine Chemicals LLC (San Diego, CA, USA).
Synthesis of 5,6-dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione 1 (Supplementary Materials).
1,2,5-Oxadiazole-3,4-dicarbohydrazide 2 (100 mg, 0.53 mmol), H2O (20 mL), and conc. HCl (0.6 mL) were added to a 50 mL three-necked flask. The mixture was stirred for 1 h at 75 °C and then cooled to room temperature; water (10 mL) was added, and the mixture was extracted with EtOAc (3 × 20 mL). The combined organic layers were dried over MgSO4, and the solvent was evaporated under reduced pressure. The residue was separated using silica gel column chromatography (eluent: CH2Cl2/EtOH = 10:1). The yield was 33 mg (41%), as a yellow solid, and Rf = 0.1 (CH2Cl2). Mp = 240–243 °C. IR spectrum, ν, cm–1: 3109, 3038, 2931, 2850, 1725, 1679, 1324, 1120, 1023, 828, 722, 641, and 511. 1H NMR (ppm): δ 10.1 (2H, s, NH). 13C NMR (ppm): δ 146.3 and 148.9. HRMS (ESI-TOF), m/z: calcd. for C4H3N4O3 [M + H]+ 155.0200 and found 155.0203. MS (EI, 70eV), m/z (I, %): 154 ([M]+, 40), 70 (20), and 30 (100). Anal. calcd. for C4H3N4O3 (288.2952): C, 30.96; H, 1.95; and N, 36.13%. Found: C, 31.25; H, 2.04 %; and N, 36.47%.

Supplementary Materials

The following are available online: copies of the 1H, 13C NMR, IR, and LR and HR mass-spectra for the compound 1.

Author Contributions

Conceptualization, O.A.R.; methodology, T.N.C.; software, T.N.C.; validation, O.A.R.; formal analysis and investigation, T.N.C. and K.S.G.; resources, T.N.C.; data curation, T.N.C.; writing—original draft preparation, O.A.R.; writing—review and editing, O.A.R.; visualization, O.A.R.; supervision, O.A.R.; project administration, O.A.R.; funding acquisition, O.A.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of compound 1 are available from the authors.

References

  1. Ogurtsov, V.A.; Dorovatovskii, P.V.; Zubavichus, Y.V.; Khrustalev, V.N.; Fakhrutdinov, A.N.; Zlotin, S.G.; Rakitin, O.A. [1,2,5]Oxadiazolo[3,4-d]pyridazine 1,5,6-trioxides: Efficient synthesis via the reaction of 3,4-bis(hydroxyimino)methyl)-1,2,5-oxadiazole 2-oxides with a mixture of concentrated nitric and trifluoroacetic acids and structural characterization. Tetrahedron Lett. 2018, 59, 3143–3146. [Google Scholar] [CrossRef]
  2. Kots, A.Y.; Khropov, Y.V.; Grafov, M.A.; Kulikov, A.S.; Ovchinnikov, I.V.; Belushkina, N.N.; Busygina, O.G.; Gavrilova, S.A.; Makhova, N.N.; Medvedeva, N.A.; et al. 1,2,5-Oxadiazolo[3,4-d]pyridazine-5,6-dioxide derivatives as activators of soluble form of guanylate-cyclase and agents active in the treatment of central nervous system diseases. Russian Patent RU2165256, 20 April 2001. [Google Scholar]
  3. Tang, Y.; He, C.; Imler, G.H.; Parrish, D.A.; Shreeve, J.M. Energetic 1,2,5-Oxadiazolo-Pyridazine and its N-Oxide. Chem. A Eur. J. 2017, 23, 15022–15025. [Google Scholar] [CrossRef]
  4. Zheng, Y.; Qi, X.; Chen, S.; Song, S.; Zhang, Y.; Wang, K.; Zhang, Q. Self-Assembly of Nitrogen-Rich Heterocyclic Compounds with Oxidants for the Development of High-Energy Materials. ACS Appl. Mater. Interfaces 2021, 13, 28390–28397. [Google Scholar] [CrossRef]
  5. Gendron, D.; Morin, P.-O.; Najari, A.; Leclerc, M. Synthesis of New Pyridazine-Based Monomers and Related Polymers for Photovoltaic Applications. Macromol. Rapid Commun. 2010, 31, 1090–1094. [Google Scholar] [CrossRef]
  6. Chmovzh, T.N.; Gaisin, K.S.; Rakitin, O.A. 4,7-Bis(1,2,3,4,4a,9a-Hexahydro-9H-carbazol-9-yl)-[1,2,5]oxadiazolo[3,4-d]pyridazine. Molbank 2021, 2021, M1295. [Google Scholar] [CrossRef]
  7. Knyazeva, E.A.; Rakitin, O.A. 4,7-Dibromo-substituted 2,1,3-benzothia(selena,oxa)diazoles and [1,2,5]thia(selena)diazolo[3,4-c]pyridines as building blocks in solar cells components. Chem. Heterocycl. Comp. 2017, 53, 855–857. [Google Scholar] [CrossRef]
  8. Chmovzh, T.N.; Knyazeva, E.A.; Mikhalchenko, L.V.; Golovanov, I.S.; Amelichev, S.A.; Rakitin, O.A. Synthesis of 4,7-dibromo derivative of ultrahigh electron-deficient [1,2,5]thiadiazolo[3,4-d]pyridazine heterocycle and its cross-coupling reactions. Eur. J. Org. Chem. 2018, 41, 5668–5677. [Google Scholar] [CrossRef]
  9. Chmovzh, T.N.; Knyazeva, E.A.; Tanaka, E.; Popov, V.V.; Mikhalchenko, L.V.; Robertson, N.; Rakitin, O.A. [1,2,5]Thiadiazolo[3,4-d]pyridazine as an internal acceptor in the D-A-π-A organic sensitizers for dye-sensitized solar cells. Molecules 2019, 24, 1588. [Google Scholar] [CrossRef] [PubMed]
  10. Korshunov, V.M.; Chmovzh, T.N.; Chkhetiani, G.R.; Taydakov, I.V.; Rakitin, O.A. New D–A–D luminophores of the [1,2,5]thiadiazolo[3,4-d]pyridazine series. Mendeleev Commun. 2022, 32, 371–373. [Google Scholar] [CrossRef]
  11. Eremeev, A.V.; Andrianov, V.G.; Piskunova, I.P. Reaction of functionally substituted vinyl ethers with 3,4-diaminofurazan and furazan-3,4-dicarboxylic acid dihydrazide. Chem. Heterocycl. Compd. 1979, 15, 261–264. [Google Scholar] [CrossRef]
  12. Chmovzh, T.N.; Knyazeva, E.A.; Lyssenko, K.A.; Popov, V.V.; Rakitin, O.A. Safe synthesis of 4,7-dibromo[1,2,5]thiadiazolo[3,4-d]pyridazine and its SNAr reactions. Molecules 2018, 23, 2576. [Google Scholar] [CrossRef] [PubMed]
Table 1. Reaction of 1,2,5-oxadiazole-3,4-dicarbohydrazide 2 with hydrochloric acid.
Table 1. Reaction of 1,2,5-oxadiazole-3,4-dicarbohydrazide 2 with hydrochloric acid.
Molbank 2023 m1649 i001
EntryTemperature, °CTime, hYield, of 1, %
175315
275225
375141
460139
590128
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chmovzh, T.N.; Gaisin, K.S.; Rakitin, O.A. 5,6-Dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione. Molbank 2023, 2023, M1649. https://doi.org/10.3390/M1649

AMA Style

Chmovzh TN, Gaisin KS, Rakitin OA. 5,6-Dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione. Molbank. 2023; 2023(2):M1649. https://doi.org/10.3390/M1649

Chicago/Turabian Style

Chmovzh, Timofey N., Karim S. Gaisin, and Oleg A. Rakitin. 2023. "5,6-Dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione" Molbank 2023, no. 2: M1649. https://doi.org/10.3390/M1649

APA Style

Chmovzh, T. N., Gaisin, K. S., & Rakitin, O. A. (2023). 5,6-Dihydro-[1,2,5]oxadiazolo[3,4-d]pyridazine-4,7-dione. Molbank, 2023(2), M1649. https://doi.org/10.3390/M1649

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop